www.stewwebb.com

Children Born From Lab Eggs Healthy

By EMMA ROSS
www.newsday.com/news/nationworld/world/wire/sns-ap-fertility-kids,0,1131877.story?coll=sns-ap-world-headlines
AP Medical Writer

June 30, 2003, 2:39 PM EDT

MADRID, Spain -- Children born after their mother's eggs were matured
in a laboratory dish appear to be healthy, according to the first
survey of babies born using the technique.

The method, which has been used to create about 250 babies worldwide,
is designed to allow normally fertile women whose partners have sperm
problems to avoid taking high levels of risky hormone injections
before their eggs are retrieved.

Danish researchers told scientists at a European fertility conference
Monday that a study of 33 babies born using the technique, known as in
vitro maturation, indicates they are normal, at least up to the age of

"This is still a small study and more children have to be born before
we reach any definitive conclusion. However, these results indicate
that the IVM method seems to be safe," said the study's leader, Dr.
Anne Lis Mikkelsen, a consultant at Herlev University Hospital in
Copenhagen, Denmark.

The technique involves removing immature eggs from the woman's ovaries
and maturing them in hormones and the mother's blood in a laboratory
dish for 28 to 36 hours. The eggs are then fertilized by direct sperm
injection and the resulting embryos are implanted in the womb.

In addition to women who are fertile, the technique is also used for
women with polycystic ovarian syndrome, who are at increased risk of a
potentially fatal reaction to hormone injections given before egg
retrieval.

Hormone injections are given to increase the number of eggs that
mature in a single menstrual cycle. Without them, normally one egg
matures and the rest die. Taking the eggs out before they mature means
smaller amounts of hormones can be given for a shorter period, or
hormone injections can be avoided entirely. About four eggs can be
retrieved this way.

The chance of pregnancy from transferring one or two embryos is 18 to
25 percent, slightly lower than for conventional IVF treatment.

Long applied in animals, in vitro maturation was first used on humans
in South Korea in 1992. It remains a highly specialized field and only
a few clinics worldwide offer the service.

There was a fear that problems such as oversized fetuses might arise,
as happened in cattle, said Dr. Johan Smitz, a hormone specialist at
the Free University of Brussels in Belgium.

Those concerns mean it is essential to monitor babies born using the
method "to see that there is really no problem of safety," said Smitz,
who was not connected with the study. "The results here are very
encouraging, but other types of studies also need to be conducted."

However, Roger Gosden, an ovary expert from the Jones Institute for
Reproductive Medicine in Norfolk, Va., warned genetic problems may not
show up in such a small study.

"Because the incidence of those sorts of syndromes is so rare -- one
in 15,000 -- you need a large series, so studying a few thousand IVM
babies is not going to answer the question," Gosden said.

The study involved 33 babies born between July 1998 and January 2000
by in vitro maturation at Mikkelsen's hospital.

One girl was born dead, but her death was thought to be related to the
failure of the placenta to operate properly rather than the method of
conception. Another girl was born with a soft palate, a common birth
defect also not thought to be related to the method.

Birth weights and the rate and type of pregnancy complications and
birth defects were normal, Mikkelsen said.

The first 18 children were also examined when they were six months, 1
and 2 years old and their parents were questioned about how their
children were performing on developmental milestones.

"We found that the development was as we could expect. In about six or
seven of the children the language skills were more developed than we
would expect, but I think that's due to the parents" and their
exceptional motivation, Mikkelsen said.

The findings were presented at the annual meeting of the European
Society of Human Reproduction and Embryology.

Copyright © 2003, The Associated Press

 
 

All logos and trademarks in this site are property of their respective owner.
FAIR USE NOTICE: This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of environmental, political, human rights, economic, democracy, scientific, and social justice issues, etc. We believe this constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. For more information go to: www.law.cornell.edu/uscode/17/107.shtml